Neurocrine Biosciences (NBIX) Tops Q4 EPS by 12c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $150.82 --0%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
CMCT, STEX, PWCM, More
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
CMCT, STEX, PWCM, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of $1.24, $0.12 better than the analyst estimate of $1.12. Revenue for the quarter came in at $412 million versus the consensus estimate of $408.87 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
